Table 4

ORs for SLE patients with different Hsp70-4 genotypes and haplotypes (Hsp70-4 and -5) based on the presence of anti-Ro and anti-La autoantibodies

Population: Hsp70-4 genotypes	Autoantibodies against	p Value	OR	95% CI
Erlangen	Ro
C/C versus T/T		0.02	2.74	1.15 to 6.52
C/C versus C/T		0.02	2.15	1.12 to 4.13
	La
C/C versus T/T		0.02	3.01	1.18 to 7.70
C/C versus C/T		NS	1.36	0.63 to 2.97
OMRF	Ro
C/C versus T/T		NS	1.27	0.68 to 2.37
C/C versus C/T		0.03	1.67	1.04 to 2.68
	La
C/C versus T/T		0.02	2.73	1.12 to 6.65
C/C versus C/T		0.001	3.24	1.53 to 6.88

Population: haplotypes (Hsp70-4 and Hsp-5)	Autoantibodies against	p Value	OR	95% CI
Erlangen	Ro
C–G/C–G versus T–G/T–G		0.004	5.14	1.57 to 16.84
C–G/C–G versus C–G/T–G		0.001	3.21	1.58 to 6.53
	La
C–G/C–G versus T–G/T–G		0.01	4.17	1.29 to 13.55
C–G/C–G versus C–G/T–G		NS	1.91	0.85 to 4.29
OMRF	Ro
C–G/C–G versus T–G/T–G		NS	1.65	0.78 to 3.50
C–G/C–G versus C–G/T–G		NS	1.65	0.97 to 2.69
	La
C–G/C–G versus T–G/T–G		0.05	2.72	0.97 to 7.66
C–G/C–G versus C–G/T–G		0.007	2.81	1.30 to 6.05